What is AngioScore?
AngioScore is an endovascular company based in Fremont, California, focused on creating advanced angioplasty catheters for treating coronary and peripheral artery disease. Its primary product, the AngioSculpt® Scoring Balloon Catheter, features a unique system of nitinol-scoring elements integrated with a standard balloon catheter. This design concentrates dilating force to minimize balloon slippage and enhance the expansion of stenotic arteries, offering a distinct advantage in interventional cardiology.
How much funding has AngioScore raised?
AngioScore has raised a total of $12M across 1 funding round:
Private Equity
$12M
Private Equity (2012): $12M with participation from California Technology Ventures, LLC, Saints capital, QuestMark Partners, Pelion Venture Partners, and Telegraph Hill Partners
Key Investors in AngioScore
California Technology Ventures, LLC
California Technology Ventures is a venture capital firm specializing in direct investments in technology and life science companies, known for its entrepreneurial approach and strategic guidance to build world-class enterprises.
Saints capital
Saints Capital is a venture secondary market investment firm founded in 2000, specializing in GP-led transactions and providing liquidity solutions for investors in private companies.
QuestMark Partners
QuestMark Partners is an expansion-stage investment firm that partners with management teams to build market-leading companies, focusing on sectors like enterprise software and healthcare IT.
What's next for AngioScore?
With the recent major strategic investment, AngioScore is poised for an accelerated growth trajectory. The substantial capital infusion, part of its $12M in total financing, will likely support expanded clinical trials, regulatory approvals, and broader commercialization efforts. The company's focus on innovative scoring balloon technology positions it to capture a larger share of the interventional cardiology market, potentially leading to further strategic partnerships or market expansion initiatives.
See full AngioScore company page
